About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Antibiotics in Chronic Obstructive Pulmonary Disease (COPD)

NCT00952861·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Odense University Hospital

With

Kolding Sygehus
Svendborg Hospital
Fredericia Hospital
Naestved Hospital
Hillerod Hospital, Denmark
Region Syddanmark
Danmarks Lungeforening
Danish National Research Foundation

Age

50–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Age above 50 years
History of smoking
History of COPD
Antibiotics for 24 hours
At least 2 of the following: dyspnoea, coughing with sputum, and sputum with purulence
Informed consent

You may not be if

Pneumonia
Antibiotics for more than 36 hours
Antibiotics for other infection
Prednisolone, more than 0.5 mg/kg body weight/24 hours for more than 3 days
Malignancy
Other pulmonary disease
Immune deficiency
Not able to tolerate doxycycline
Severe heart, liver or kidney disease
Epilepsia
Not stable 24 hours after hospital admission
Need for assisted ventilation

The record

StatusWithdrawn

PhasePhase 4

Taking part140

StartedOct 2009

UpdatedAug 11, 2010

Conditions

Pulmonary Disease, Chronic Obstructive

Where1

Odense University Hospital
Odense, Denmark

Clareo Health | Antibiotics in Chronic Obstructive Pulmonary Disease (COPD)